 |
|
|
Newsroom
|
|
Listed
below are newsworthy events and dates as announced by the company's
board of directors or as chronicled in the press:
2005 Press Releases
2004 Press Releases
- (December 14, 2004) GTx
Acquires Exclusive Rights in the U.S. for Toremifene in All Indications
- (November 22, 2004) GTx, Inc. to Present at the Lazard Life Sciences Conference
- (November 15, 2004) GTx, Inc. to Present at the SG Cowen 5th Annual Global Healthcare Conference
- (November 12, 2004) Semi-Annual Changes to the NASDAQ Biotechnology Index
- (November 11, 2004) GTx,
Inc. Reports Third Quarter Financial Results
- (October 28, 2004) GTx, Inc. Announces Release of Third
Quarter Financial Results, Conference Call and Webcast
- (October 7,
2004) GTx, Inc. Announces the Appointment of Timothy R. G. Sear
to its Board of Directors
- (September 22,
2004) GTx, Inc. to Webcast Analyst Meeting Wednesday, September
29, 2004
- (July 29, 2004)
GTx, Inc. Reports Second Quarter 2004 Financial Results
- (July 27, 2004)
GTx, Inc. Collaborates with Tessera, Inc. to Develop a Diagnostic
Test to Detect High Grade PIN
- (July 16, 2004)
GTx, Inc. to Present New Phase IIb Clinical Trial Data for ACAPODENE™
at the Fourth International Prostate Cancer Congress
- (July 9, 2004)
GTx, Inc. Announces Release of Second Quarter Financial Results,
Conference Call and Webcast
- (June 15, 2004)
GTx, Inc. Collaborates with diaDexus, Inc to Develop a Diagnostic
Test for High Grade PIN
- (June 7, 2004)
GTx, Inc. Presents Positive Preclinical and Clinical Data for
ACAPODENE™ at the American Society of Clinical Oncology
Meeting
- (June 2, 2004)
GTx, Inc. Announces Positive Phase IIb Data for ACAPODENE™
for the Prevention of Prostate Cancer in High Risk Men
- (April 22, 2004)
GTx, Inc. Collaborates with Beckman Coulter Subsidiary, Hybritech
to Supply High Grade PIN Samples for Research and Evaluation of
Prostate Cancer Markers
- (April 19, 2004)
GTx, Inc. Reports First Quarter 2004 Financial Results
- (April 13, 2004)
GTx, Inc. Initiates Urology Resident Research Fellowship Program
- (April 07, 2004)
GTx, Inc. Announces Release of Quarterly Financial Results, Conference
Call and Webcast
- (March 17, 2004)
GTx, Inc. Enters into a Worldwide Collaboration, License and Co-Promotion
Agreement with Ortho Biotech Products, L.P., for Andarine, a Selective
Androgen Receptor Modulator (SARM)
- (March 5, 2004)
GTx, Inc. to Present at the 24th Annual SG Cowen Healthcare Conference
- (March 3, 2004)
GTx, Inc. Reports Fourth Quarter and Year-End 2003 Financial Results
- (March 2, 2004)
GTx, Inc. Announces the Appointments of Andrew M. Clarkson and
J. Kenneth Glass to its Board of Directors
- (February 25,
2004) GTx, Inc. Announces Financial Release, Conference Call and
Webcast
- (February 11,
2004) GTx, Inc. Announces Appointment of Director of Marketing
and Sales to Management Team
- (February 03,
2004) GTx, Inc. Announces Initial Public Offering
- (January 09,
2004) GTx, Inc. Initiates 2-Year Internship Program for Area College
Students Pursuing Degrees in Science
2003 Press Releases
|
|
